A study published in Cell Stem Cell looks at stem cell therapy for treating progressive multiple sclerosis. Dr Aravinthan Varatharaj, Clinical … read more
A study published in the Journal of Neurology Neurosurgery & Psychiatry looks at the use of stem cells to treat MS. … read more
A study published in Journal of Neurology Neurosurgery & Psychiatry looks at sleep during adolescence and risk of multiple sclerosis. … read more
A study published in Science looks at Epstein-Barr virus and multiple sclerosis (MS). Prof Paul Farrell, Professor of Tumour Virology, … read more
A study, published in the New England Journal of Medicine, looked at the drug ofatumumab for multiple sclerosis in a phase … read more
A study, published in Acta Neuropathologica, looked at a molecular target to protect nerves from damage in multiple sclerosis. … read more
Research published in JAMA demonstrates that in patients with MS, Hematopoietic stem cell transplantation (HSCT),when compared with disease-modifying therapy (DMT), resulted in a longer time to diseases … read more
In a new study published in Molecular Therapy researchers – using gene immunotherapy – were able to demonstrate the prevention and reversing of the symptoms of multiple sclerosis (MS) in mice. read more
The European Court of Justice has ruled that judges are able to consider that vaccination may lead to the development of an illness, in the absence of scientific evidence. This ruling was made in relation to a case in France of a man claiming that a hepatitis B vaccination he received led to the development of multiple sclerosis. read more
A new population-based cohort study published in The Lancet reports living close to heavy traffic was associated with a small, yet significant, increase in the incidence of dementia, but not Parkinson’s disease or multiple sclerosis.
A paper published in the Lancet journal has looked at treatment of multiple sclerosis and reports the efficacy of chemotherapy to ablate the immune system followed by a stem cell transplant. read more
A study looking at the prevalence of multiple sclerosis (MS) in different ethnic groups has been published in the Multiple Sclerosis Journal. The authors report higher prevalence in the white population compared to the black and South Asian populations of the same area of east London, which was in turn higher than the prevalence of MS in Africa and South Asia. read more
A possible link between vitamin D levels and risk of multiple sclerosis (MS) has been explored in a paper published in the journal PLOS Medicine, in which the authors report that gene variants which were associated with lower levels of vitamin D were associated with an increased risk for MS. read more
A paper published in the journal Nature has described the use of two drugs in mouse models of multiple sclerosis, reporting the ability of the drugs to repair specific parts of damaged nerve cells and to reduce disease severity. read more
A paper published in Science Translational Medicine reported a successful Phase I clinical trial which tested a treatment to “reset” the immune systems of multiple sclerosis patients, finding it reduced their antimyelin immune responses by 50 to 75%. read more
A review in Drug and Therapeutics Bulletin called into question the evidence backing the use of cannabis extract in the treatment of Multiple Sclerosis (MS). read more
A small study published online in The Journal of Neurology Neurosurgery and Psychiatry suggested in vitro fertilisation (IVF) was linked to an increased rate of relapse among women with multiple sclerosis (MS). read more
The preliminary results of CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) were presented at the annual meeting of the Association of British Neurologists, suggesting cannabis did not slow progression of MS as hoped. read more
In the largest investigation yet into the genetics of multiple sclerosis, a major international collaboration doubled the number of genetic variations linked to the disease, offering clues to how it develops and possible targets for therapeutic treatments. The study was published in Nature and was led by researchers from Cambridge and Oxford. read more
The potential of stem cells as a treatment for multiple sclerosis (MS) has been widely reported, but whether they will fulfil that potential remains unclear. A new £1million partnership between the MS Society and the UK Stem Cell Foundation (UKSCF) will, for the first time, provide specific funding for stem cell research in MS. Experts in the field briefed journalists on what the future holds, in particular, the promise of neural stem cells and the possibilities for repairing the damaged central nervous system. read more
